UCP1 and metabolic dysfunction-associated steatohepatitis: Sustained high-fat conditions downregulate UCP1 expression, with lower UCP1 levels driving necroptosis in NK cells, thereby compromising their ability to suppress the advancement of NASH-associated fibrosis [149].